These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25760284)

  • 1. The role of p21-activated kinases in pancreatic cancer.
    Yeo D; He H; Baldwin GS; Nikfarjam M
    Pancreas; 2015 Apr; 44(3):363-9. PubMed ID: 25760284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation.
    Wang K; Baldwin GS; Nikfarjam M; He H
    World J Gastroenterol; 2018 Sep; 24(33):3709-3723. PubMed ID: 30197477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group II p21-activated kinases as therapeutic targets in gastrointestinal cancer.
    Shao YG; Ning K; Li F
    World J Gastroenterol; 2016 Jan; 22(3):1224-35. PubMed ID: 26811660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of p21-activated kinases (PAKs).
    Rudolph J; Crawford JJ; Hoeflich KP; Wang W
    J Med Chem; 2015 Jan; 58(1):111-29. PubMed ID: 25415869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P21 activated kinase signaling in cancer.
    Rane CK; Minden A
    Semin Cancer Biol; 2019 Feb; 54():40-49. PubMed ID: 29330094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of p-21-activated kinases in cancer progression.
    King H; Nicholas NS; Wells CM
    Int Rev Cell Mol Biol; 2014; 309():347-87. PubMed ID: 24529727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p21-activated kinase 4: a druggable target in the elusive oncogenic KRAS pathway?
    Azmi AS; Mohammad RM
    Future Med Chem; 2015; 7(1):5-7. PubMed ID: 25582328
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of group 1 p21-activated kinases suppresses pancreatic stellate cell activation and increases survival of mice with pancreatic cancer.
    Yeo D; Phillips P; Baldwin GS; He H; Nikfarjam M
    Int J Cancer; 2017 May; 140(9):2101-2111. PubMed ID: 28109008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting group II PAKs in cancer and metastasis.
    Eswaran J; Soundararajan M; Knapp S
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):209-17. PubMed ID: 19160016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P21-activated kinase 4--not just one of the PAK.
    Dart AE; Wells CM
    Eur J Cell Biol; 2013; 92(4-5):129-38. PubMed ID: 23642861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of P21-activated kinases 1 and 4 synergistically suppresses the growth of pancreatic cancer by stimulating anti-tumour immunity.
    Ma Y; Dumesny C; Dong L; Ang CS; Asadi K; Zhan Y; Nikfarjam M; He H
    Cell Commun Signal; 2024 May; 22(1):287. PubMed ID: 38797819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of p21 Activated Kinase 1 (PAK1) in the invasion and motility of oral cancer cells.
    Parvathy M; Sreeja S; Kumar R; Pillai MR
    BMC Cancer; 2016 May; 16 Suppl 1(Suppl 1):293. PubMed ID: 27229476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The trilogy of P21 activated kinase, autophagy and immune evasion in pancreatic ductal adenocarcinoma.
    Ma Y; Nikfarjam M; He H
    Cancer Lett; 2022 Nov; 548():215868. PubMed ID: 36027997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.
    McCarty SK; Saji M; Zhang X; Jarjoura D; Fusco A; Vasko VV; Ringel MD
    Endocr Relat Cancer; 2010 Dec; 17(4):989-99. PubMed ID: 20817787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.
    Tabusa H; Brooks T; Massey AJ
    Mol Cancer Res; 2013 Feb; 11(2):109-21. PubMed ID: 23233484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p21-activated kinase 1: PAK'ed with potential.
    Ong CC; Jubb AM; Zhou W; Haverty PM; Harris AL; Belvin M; Friedman LS; Koeppen H; Hoeflich KP
    Oncotarget; 2011 Jun; 2(6):491-6. PubMed ID: 21653999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting p21 activated kinase 1 (Pak1) to PAKup Pancreatic Cancer.
    Jagadeeshan S; Venkatraman G; Rayala SK
    Expert Opin Ther Targets; 2016 Nov; 20(11):1283-1285. PubMed ID: 27654702
    [No Abstract]   [Full Text] [Related]  

  • 18. p21-activated kinase inhibitors.
    Rudolph J; Crawford JJ; Hoeflich KP; Chernoff J
    Enzymes; 2013; 34 Pt. B():157-80. PubMed ID: 25034104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of p21-activated kinases in cardiovascular development and function.
    Kelly ML; Astsaturov A; Chernoff J
    Cell Mol Life Sci; 2013 Nov; 70(22):4223-8. PubMed ID: 23640572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAK4 pathway as a potential therapeutic target in pancreatic cancer.
    Thillai K; Sarker D; Wells C
    Future Oncol; 2018 Mar; 14(7):579-582. PubMed ID: 29508632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.